Erythromelalgia: response to serotonin reuptake inhibitors.
Rudikoff
D
D
Department of Dermatology, Mt. Sinai School of Medicine, New York, NY 10029-6574, USA.
Jaffe
I A
IA
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D004916:Erythromelalgia / Q000188:drug therapy*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline; D000069470:Venlafaxine Hydrochloride
D015057:1-Naphthylamine; D003511:Cyclohexanols; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D000069470:Venlafaxine Hydrochloride